SVRA Savara Inc
Nasdaq · SEC CIK 1160308 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.36M 2 sales by 2 insiders
- Filings on record
- 119 since 2021-08-18, latest 2026-07-24 18:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Lowrance David L | CFO | — | $2.24M |
| RAMSAY DAVID A | Dir | — | $121.2K |
| Wasfi Yasmine | Chief Medical Off | — | — |
| McCabe Kathleen R. | CLO | — | — |
| Erickson Anne | Chief Business Off | — | — |
| van Es-Johansson An | Dir | — | — |
| Lutz Robert Matthew | Chief Fin, Operating Off | — | — |
| McCracken Joseph S | Dir | — | — |
| Pauls Matthew | CEO, Dir | — | — |
| Elam Nevan C | Dir | — | — |
Transactions 127
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-27 | 2022-09-23+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.38 | +135.0K | 1.88M | +8% | +$186.8K |
| M | 2022-09-20 | 2022-09-16+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.44 | +8,000 | 1.74M | +0.5% | +$11.6K |
| M | 2022-09-08 | 2022-09-06+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.40 | +32.0K | 1.73M | +2% | +$44.8K |
| M | 2022-09-01 | 2022-08-30+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.42 | +100.0K | 1.70M | +6% | +$141.8K |
| M | 2022-06-22 | 2022-06-17+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.39 | +100.0K | 1.56M | +7% | +$138.7K |
| 2022-01-03 | 2021-12-31 | SVRA | Pauls Matthew | CEO, Dir | F - Tax | $1.24 | -62.3K | 721.4K | -8% | -$77.3K | |
| M | 2021-12-30 | 2021-12-29+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.28 | +50.0K | 1.50M | +3% | +$64.2K |
| 2021-12-17 | 2021-12-17 | SVRA | Lowrance David L | CFO | P - Purchase | $1.14 | +4,000 | 142.8K | +3% | +$4,560 | |
| M | 2021-12-17 | 2021-12-15+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.11 | +40.0K | 1.45M | +3% | +$44.5K |
| D | 2021-12-14 | 2021-12-14 | SVRA | Chowdhury Badrul A. | Chief MEDICAL Off | A - Grant | $0.00 | +125.0K | 300.0K | +71% | $0 |
| D | 2021-12-14 | 2021-12-13 | SVRA | Hawkins Richard J | Dir | M - OptEx | $0.55 | +728 | 728 | New | +$400.40 |
| D | 2021-12-14 | 2021-12-14 | SVRA | Lowrance David L | CFO | A - Grant | $0.00 | +125.0K | 138.8K | +906% | $0 |
| D | 2021-12-14 | 2021-12-14 | SVRA | Pauls Matthew | CEO, Dir | A - Grant | $0.00 | +400.0K | 783.7K | +104% | $0 |
| 2021-12-13 | 2021-12-10 | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.04 | +35.0K | 1.41M | +3% | +$36.4K | |
| M | 2021-12-09 | 2021-12-07+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.05 | +25.0K | 1.38M | +2% | +$26.2K |
| 2021-12-09 | 2021-12-09 | SVRA | Chowdhury Badrul A. | Chief MEDICAL Off | P - Purchase | $1.05 | +25.0K | 175.0K | +17% | +$26.2K | |
| D | 2021-12-08 | 2021-12-06 | SVRA | Elam Nevan C | Dir | M - OptEx | $0.55 | +1,172 | 28.1K | +4% | +$644.60 |
| 2021-12-08 | 2021-12-08 | SVRA | Pauls Matthew | CEO, Dir | P - Purchase | $1.06 | +6,500 | 383.7K | +2% | +$6,890 | |
| M | 2021-12-02 | 2021-12-01+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.09 | +25.0K | 1.33M | +2% | +$27.2K |
| 2021-12-02 | 2021-12-02 | SVRA | Pauls Matthew | CEO, Dir | P - Purchase | $1.10 | +10.0K | 377.2K | +3% | +$11.0K | |
| M | 2021-12-01 | 2021-11-30+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.09 | +25.0K | 1.32M | +2% | +$27.3K |
| M | 2021-11-22 | 2021-11-18+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.08 | +200.0K | 1.16M | +21% | +$215.5K |
| M | 2021-11-22 | 2021-11-18+ | SVRA | Pauls Matthew | CEO, Dir | P - Purchase | $1.10 | +22.1K | 365.0K | +6% | +$24.4K |
| M | 2021-09-30 | 2021-09-28+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.29 | +137.1K | 1.00M | +16% | +$176.8K |
| D | 2021-08-19 | 2021-08-18 | SVRA | Elam Nevan C | Dir | M - OptEx | $0.52 | +2,288 | 26.9K | +9% | +$1,190 |
| M | 2021-08-19 | 2021-08-17+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.19 | +97.3K | 964.1K | +11% | +$115.5K |
| M | 2021-08-18 | 2021-08-17+ | SVRA | Pauls Matthew | CEO, Dir | P - Purchase | $1.18 | +26.9K | 333.1K | +9% | +$31.9K |
Purchase Sale Sale after option exercise All abbreviations